Peripheral neuropathy decisions — 2025

The Board denied service connection for multiple conditions, including a lumbar spine disorder and various peripheral neuropathies, as the probative evidence did not support a finding that these conditions were related to the Veteran's active military service.

The Board granted service connection for peripheral neuropathy of the left and right lower extremities due to exposure to herbicide agents, finding that the evidence supports a relationship between the Veteran's in-service exposure and his current condition.

The Board granted service connection for right sacroiliitis and bilateral lower extremity radiculopathy, both secondary to the Veteran's service-connected thoracolumbar degenerative disc disease, as well as earlier effective dates for the award of service connection for left and right lower extremity peripheral neuropathy of the sciatic nerve.

The Board granted earlier effective dates for the Veteran's diabetic peripheral neuropathy and denied an earlier effective date for PTSD, while granting ratings of 20 percent for diabetes mellitus during certain periods.

The Board remands the service connection claims for coronary artery disease, bladder tumor, and peripheral neuropathy of both upper and lower extremities to correct duty to assist errors related to toxic exposure risk activities during active service.

The Board granted a rating of 40 percent for left upper, left lower, and right lower extremity neuropathy but remanded the claims for service connection for a left hip disability and entitlement to TDIU.

The Board remands the claims for service connection for right and left lower extremity peripheral neuropathy to obtain a more complete medical examination.

The Board dismissed the appeals for increased ratings and TDIU as moot because the benefits sought have already been granted effective May 27, 2022.

The Board denied the Veteran's claims for increased disability ratings for diabetic peripheral neuropathy of both upper extremities, finding that the evidence did not support a rating in excess of 20 percent.

The Board granted an initial 30 percent rating for right upper extremity peripheral neuropathy, a 20 percent rating for left upper extremity peripheral neuropathy, and a 10 percent rating for hypertension. The claim for an initial compensable rating for bilateral hearing loss was denied.

The appeal was dismissed due to the Veteran's death while it was pending.

The Board denied an effective date earlier than July 10, 2023, for the grant of a 10 percent disability rating for the service-connected left fourth toe disability.

The Board granted service connection for low back disability, to include pain, and left and right lower extremity peripheral neuropathy, to include as due to the service-connected back disability.

The Board granted service connection for chronic pain syndrome and pudendal neuropathy, finding that the Veteran's Agent Orange exposure was a proximate cause in his development of these conditions.

The Board denied service connection for IBS, chronic fatigue syndrome, and increased ratings for bilateral foot conditions and bilateral hearing loss. The TBI, cervical spine, left knee, right knee, lower left extremity neurological condition, lower right extremity neurological condition, and neuropathy of the right ankle residuals were remanded.

The Board granted service connection for right upper extremity neuropathy, finding it to be secondary to a service-connected cervical spine disability.

The Board remands the claims for a higher rating and service connection due to an error in providing notice of the Veteran's right to a pre-decisional hearing.

The Board denied earlier effective dates for the awards of service connection for diabetes mellitus, left and right lower extremity diabetic neuropathy, and higher ratings for residuals of a gunshot wound to the left leg with fractured tibia and fibula, injury to muscle group XII, shortening of the leg, damage to the peroneal nerve, radiculopathy, and diabetic neuropathy, but granted an initial 20% rating for right lower extremity diabetic neuropathy.

The Board remands the issue of entitlement to compensation under 38 U.S.C. § 1151 for sensory neuropathy, right femoral nerve, secondary to VA treatment provided in January 2012, due to incomplete records and unreadable signatures.

The Board remands the matters for additional development, including an SSOC to be issued after receiving any new evidence.